Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease
Alejandro Valencia-Rodríguez; Alfonso Vera-Barajas; Norberto C. Chávez-Tapia; Misael Uribe; Nahum Méndez-Sánchez;
Ann Hepatol. 2020;19:227-9
Assessment of TLL1 variant and risk of hepatocellular carcinoma in Latin Americans and Europeans
Siyu Fu; Dhamina Karim; Jhon Prieto; Domingo Balderramo; Javier Diaz Ferrer; Angelo Z. Mattos; Marco Arrese; Enrique Carrera; Jeffrey Oliveira; Jose D. Debes; Andre Boonstra;
Ann Hepatol. 2024;29:
Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía; Xingshun Qi; Ludovico Abenavoli; Manuel Romero-Gómez; Mohammed Eslam; Nahum Méndez-Sánchez;
Ann Hepatol. 2023;28: